Slip Clinical Corp Proclaims Unusual Slip with the Experts Video That contains Mark Seraly, MD

Dr. Seraly discusses severe recalcitrant acne, including nodular, inflammatory and cystic acne

SCOTTSDALE, Ariz.July 9, 2021PRLog — Slip Clinical Company (Slip Clinical) as of late released a new Slip with the Experts video featuring Mark Seraly, MD, a board-licensed dermatologist with Seraly Dermatology in Peters Township, Pennsylvania. Dr. Seraly sits down with Slip Clinical to train about severe recalcitrant acne, including what it’s, why it occurs and how those affected can see medication from their local dermatology apply.

Extreme recalcitrant acne entails nodular, inflammatory and cystic acne. These type of acne are more serious than a same outdated pimple and impact deeper layers of the skin. To search the Slip with the Experts video featuring Dr. Seraly, please consult with

About Slip with the Experts

Slip with the Experts is a tutorial initiative supported by Slip Clinical Company, the scientific dermatology company. The initiative is designed to order the basic public on overall scientific dermatology skin problems and point out how these stipulations will also be treated at local dermatology practices.

About Slip Clinical Company

Slip Clinical is centered on figuring out, acquiring and strategically commercializing innovative, differentiated dermatology merchandise by its efficient sales and marketing mannequin. The corporate presently markets seven merchandise that attend address and heal overall skin stipulations. The Slip Clinical crew is constituted of commerce experts with huge ride commercializing some of primarily the most winning prescription dermatology producers. Slip Clinical is found in Scottsdale, Arizona and is a partner company of Fortress Biotech, Inc. (NASDAQ:FBIO). For more files about Slip Clinical, consult with

About Mark Seraly, MD

Dr. Seraly is a board-licensed dermatologist with over 23 years of scientific ride. Dr. Seraly is a graduate of Jefferson Clinical College in Philadelphia, PA and completed his residency and chief residency in dermatology at the College of Pittsburgh. He’s the recipient of a big sequence of honors and awards including membership in many academic honor societies.

Dr. Seraly has authored 37 scientific publications and has been invited as a visitor lecturer over 200 times in 23 U.S. states and 11 cities in 7 out of the country nations. He’s an active member of many legit scientific societies, primitive adjunct instructing faculty for the College of Pittsburgh Division of Dermatology residency program, and runs a non-public apply in Peters Township, PA. Dr. Seraly’s particular pursuits in dermatology consist of acne, rosacea, skin most cancers, beauty dermatology, infectious skin diseases, autoimmune problems and teledermatology. For more files about Dr. Seraly, please consult with

Forward-Trying Statements

This press open could perhaps simply have “forward-taking a sight statements” correct by the that methodology of Piece 27A of the Securities Act of 1933 and Piece 21E of the Securities Replace Act of 1934, as amended. As primitive below and correct by this press open, the phrases “we”, “us” and “our” could perhaps simply consult with Fortress for my share, a partner company for my share, or Fortress along with one or more partner corporations, as dictated by context. Such statements consist of, but are not restricted to, any statements referring to to our convey technique and product model functions and any various statements that are not historical details. Forward-taking a sight statements are primarily primarily based on management’s recent expectations and are discipline to risks and uncertainties that could perhaps negatively impact our industry, operating results, monetary situation and stock price. Elements that could perhaps field off precise results to change materially from those presently anticipated consist of: risks referring to to our convey technique; our skill to construct, fabricate below and exhaust financing and strategic agreements and relationships; risks referring to to the outcomes of research and model activities; uncertainties referring to to preclinical and scientific testing; risks referring to to the timing of starting and finishing scientific trials; our dependence on third-social gathering suppliers; our skill to blueprint, mix and abet key personnel; the early stage of merchandise below model; our need for enormous additional funds; authorities regulation; patent and intellectual property matters; opponents; as neatly as various risks described in our SEC filings. We expressly disclaim any responsibility or enterprise to open publicly any updates or revisions to any forward-taking a sight statements contained herein to mediate any exchange in our expectations or any adjustments in events, stipulations or circumstances on which the type of observation is primarily primarily based, except as could perhaps be required by regulation.


Jaclyn Jaffe and Bill Begien

Fortress Biotech, Inc.

[email protected]

(781) 652-4500

Related Articles

Back to top button
%d bloggers like this: